ติดตาม
Amal Hofni
Amal Hofni
ยืนยันอีเมลแล้วที่ svu.edu.eg
ชื่อ
อ้างโดย
อ้างโดย
ปี
Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats
A Hofni, MA El-Moselhy, A Taye, MM Khalifa
European Journal of Pharmacology 744, 173-182, 2014
382014
Ginger extract–loaded transethosomes for effective transdermal permeation and anti-inflammation in rat model
AS Hassan, A Hofni, MAS Abourehab, IAM Abdel-Rahman
International Journal of Nanomedicine, 1259-1280, 2023
362023
Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase
A Hofni, BA Shehata Messiha, SA Mangoura
Naunyn-Schmiedeberg's archives of pharmacology 390, 801-811, 2017
232017
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer …
MAE Mourad, A Abo Elmaaty, I Zaki, AAE Mourad, A Hofni, AE Khodir, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2205043, 2023
202023
Renoprotective Effect of thymoquinone against streptozotocin-induced diabetic nephropathy: Role of NOX2 and Nrf2 signals
A Hofni, FEM Ali, ARN Ibrahim, EM Aboubaker
Current Molecular Pharmacology 16 (8), 905-914, 2023
72023
Fasudil ameliorates methotrexate-induced hepatotoxicity by modulation of redox-sensitive signals
EM Aboubakr, ARN Ibrahim, FEM Ali, AAE Mourad, AM Ahmad, A Hofni
Pharmaceuticals 15 (11), 1436, 2022
62022
Selective Targeting of the Novel CK-10 Nanoparticles to the MDA-MB-231 Breast Cancer Cells
G Samuel, U Nazim, A Sharma, V Manuel, MG Elnaggar, A Taye, ...
Journal of Pharmaceutical Sciences 111 (4), 1197-1207, 2022
42022
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–7